Connor T Watson, Christopher A Siedlecki, Keefe B Manning
{"title":"GPVI 介导的血栓稳定微流体狭窄中剪切力诱导的血小板聚集。","authors":"Connor T Watson, Christopher A Siedlecki, Keefe B Manning","doi":"10.1016/j.bpj.2024.11.018","DOIUrl":null,"url":null,"abstract":"<p><p>Supraphysiological shear rates (>2,000 s<sup>-1</sup>) amplify von Willebrand factor (vWF) unfurling and increase platelet activation and adhesion. These elevated shear rates and shear rate gradients also play a role in shear-induced platelet aggregation (SIPA). The primary objective of this study is to investigate the contributions of major binding receptors to platelet deposition and SIPA in a stenotic model. Microfluidic channels with stenotic contractions ranging from 0-75% are fabricated and coated with human type I collagen at 100 μg/mL. Fresh human blood is reconstituted to 40% HCT and treated to stain platelets. Platelet receptors α<sub>IIb</sub>β<sub>3</sub>, GPIb, or GPVI are blocked with inhibitory antibodies or proteins to reduce platelet function under flow at 500, 1,000, 5,000, or 10,000 s<sup>-1</sup> over 5 minutes of perfusion. Additional validation experiments are performed by dual-blocking receptors and performing coagulability testing by rotational thromboelastometry. Control samples exhibit SIPA correlating to increasing shear rate and increasing stenotic contraction. Inhibition of α<sub>IIb</sub>β<sub>3</sub> or GPIb receptors causes a nearly total reduction in platelet adhesion and a loss of aggregation at >1,000 s<sup>-1</sup>. GPVI inhibition does not notably reduce platelet adhesion at 500 or 1,000 s<sup>-1</sup> but affects microthrombus stability at 5-10,000 s<sup>-1</sup> following aggregation formation in 50-75% stenotic channels. Inhibition of vWF-binding receptors completely blocks adhesion and aggregation at shear rates >1,000 s<sup>-1</sup>. Inhibition of GPVI reduces platelet adhesion at 5-10,000 s<sup>-1</sup> but renders thrombi susceptible to fragmentation. This study yields further insight into mechanisms regulating rapid growth and stabilization of arterial thrombi at supraphysiological shear rates.</p>","PeriodicalId":8922,"journal":{"name":"Biophysical journal","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GPVI-Mediated Thrombus Stabilization of Shear-Induced Platelet Aggregates in a Microfluidic Stenosis.\",\"authors\":\"Connor T Watson, Christopher A Siedlecki, Keefe B Manning\",\"doi\":\"10.1016/j.bpj.2024.11.018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Supraphysiological shear rates (>2,000 s<sup>-1</sup>) amplify von Willebrand factor (vWF) unfurling and increase platelet activation and adhesion. These elevated shear rates and shear rate gradients also play a role in shear-induced platelet aggregation (SIPA). The primary objective of this study is to investigate the contributions of major binding receptors to platelet deposition and SIPA in a stenotic model. Microfluidic channels with stenotic contractions ranging from 0-75% are fabricated and coated with human type I collagen at 100 μg/mL. Fresh human blood is reconstituted to 40% HCT and treated to stain platelets. Platelet receptors α<sub>IIb</sub>β<sub>3</sub>, GPIb, or GPVI are blocked with inhibitory antibodies or proteins to reduce platelet function under flow at 500, 1,000, 5,000, or 10,000 s<sup>-1</sup> over 5 minutes of perfusion. Additional validation experiments are performed by dual-blocking receptors and performing coagulability testing by rotational thromboelastometry. Control samples exhibit SIPA correlating to increasing shear rate and increasing stenotic contraction. Inhibition of α<sub>IIb</sub>β<sub>3</sub> or GPIb receptors causes a nearly total reduction in platelet adhesion and a loss of aggregation at >1,000 s<sup>-1</sup>. GPVI inhibition does not notably reduce platelet adhesion at 500 or 1,000 s<sup>-1</sup> but affects microthrombus stability at 5-10,000 s<sup>-1</sup> following aggregation formation in 50-75% stenotic channels. Inhibition of vWF-binding receptors completely blocks adhesion and aggregation at shear rates >1,000 s<sup>-1</sup>. Inhibition of GPVI reduces platelet adhesion at 5-10,000 s<sup>-1</sup> but renders thrombi susceptible to fragmentation. This study yields further insight into mechanisms regulating rapid growth and stabilization of arterial thrombi at supraphysiological shear rates.</p>\",\"PeriodicalId\":8922,\"journal\":{\"name\":\"Biophysical journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biophysical journal\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.bpj.2024.11.018\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biophysical journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.bpj.2024.11.018","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
GPVI-Mediated Thrombus Stabilization of Shear-Induced Platelet Aggregates in a Microfluidic Stenosis.
Supraphysiological shear rates (>2,000 s-1) amplify von Willebrand factor (vWF) unfurling and increase platelet activation and adhesion. These elevated shear rates and shear rate gradients also play a role in shear-induced platelet aggregation (SIPA). The primary objective of this study is to investigate the contributions of major binding receptors to platelet deposition and SIPA in a stenotic model. Microfluidic channels with stenotic contractions ranging from 0-75% are fabricated and coated with human type I collagen at 100 μg/mL. Fresh human blood is reconstituted to 40% HCT and treated to stain platelets. Platelet receptors αIIbβ3, GPIb, or GPVI are blocked with inhibitory antibodies or proteins to reduce platelet function under flow at 500, 1,000, 5,000, or 10,000 s-1 over 5 minutes of perfusion. Additional validation experiments are performed by dual-blocking receptors and performing coagulability testing by rotational thromboelastometry. Control samples exhibit SIPA correlating to increasing shear rate and increasing stenotic contraction. Inhibition of αIIbβ3 or GPIb receptors causes a nearly total reduction in platelet adhesion and a loss of aggregation at >1,000 s-1. GPVI inhibition does not notably reduce platelet adhesion at 500 or 1,000 s-1 but affects microthrombus stability at 5-10,000 s-1 following aggregation formation in 50-75% stenotic channels. Inhibition of vWF-binding receptors completely blocks adhesion and aggregation at shear rates >1,000 s-1. Inhibition of GPVI reduces platelet adhesion at 5-10,000 s-1 but renders thrombi susceptible to fragmentation. This study yields further insight into mechanisms regulating rapid growth and stabilization of arterial thrombi at supraphysiological shear rates.
期刊介绍:
BJ publishes original articles, letters, and perspectives on important problems in modern biophysics. The papers should be written so as to be of interest to a broad community of biophysicists. BJ welcomes experimental studies that employ quantitative physical approaches for the study of biological systems, including or spanning scales from molecule to whole organism. Experimental studies of a purely descriptive or phenomenological nature, with no theoretical or mechanistic underpinning, are not appropriate for publication in BJ. Theoretical studies should offer new insights into the understanding ofexperimental results or suggest new experimentally testable hypotheses. Articles reporting significant methodological or technological advances, which have potential to open new areas of biophysical investigation, are also suitable for publication in BJ. Papers describing improvements in accuracy or speed of existing methods or extra detail within methods described previously are not suitable for BJ.